2027 ICD-10-CM Diagnosis Code D70.2Other drug-induced agranulocytosis
ICD-10-CM Codes›D50–D89›D70-D77›D70
- Billable — Valid for Submission
- Not Chronic
D70.2 is a billable ICD-10-CM diagnosis code for other drug-induced agranulocytosis. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 808 through 810. Coders also document this condition as agranulocytosis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Diseases of white blood cells and Drug induced or toxic related condition.
D70.2 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 47 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 47, ESRD (V21) category 47, and ESRD (V24) category 47 for payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
D70.2 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Agranulocytosis
- Agranulocytosis caused by antithyroid agent
- B cell lymphocyte aplasia caused by drug
- Chloramphenicol-induced neutropenia
- Dose-related drug-induced neutropenia
- Drug-induced neutropenia
- Leukopenia caused by drug
- Lymphocyte count below reference range
- Non dose-related drug-induced neutropenia
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to D70.2: its own notes plus those printed at D70 and Chapter 3. A note printed at a category, block or chapter applies to every code under it.
Includes
Further defines, or gives examples of, the content of the category.
- agranulocytosis
- decreased absolute neurophile count (ANC)
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use Additional Code
Add a second code, after this one, to fully describe the condition.
Code Also
A second code may be needed to fully describe the condition; the note gives no sequencing direction.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name D70.2, its category, or a range that includes it.
Excludes2 4
These codes carry an Excludes2 note naming D70.2: its condition is not part of those codes, and both may be reported when the patient has both.
- D61 Other aplastic anemias and other bone marrow failure syndromesneutropenia (D70.-) names D70.-, which includes this code
- D72 Other disorders of white blood cellsneutropenia (D70) names D70, which includes this code
- D72.81 Decreased white blood cell countneutropenia (D70) names D70, which includes this code
- Block R70-R79 Abnormal findings on examination of blood, without diagnosis
Code First 1
These codes say to code first a condition named in the note, and D70.2 is one of the conditions named.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Agranulocytosis (chronic) (cyclical) (genetic) (infantile) (periodic) (pernicious) See Also: Neutropenia; D70.9
drug-induced D70.2
drug-induced D70.2
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Neutropenia
a decrease in the number of neutrophils found in the blood.
Patient EducationClinical
Blood Disorders
Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D70.2 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D70.2Overview
What is the ICD-10 code for other drug-induced agranulocytosis?
The ICD-10-CM code for other drug-induced agranulocytosis is D70.2 (sometimes written as D702). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is D70.2 (Neutropenia) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other drug-induced agranulocytosis on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does D70.2 group to?
When other drug-induced agranulocytosis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 808, 809, 810, with relative weights from 1.0749 to 2.1706 depending on complications. Higher weights mean higher Medicare reimbursement.
Can D70.2 be reported with D73.81?
Not as a rule. The Excludes1 note at D70, which applies to D70.2, lists "neutropenic splenomegaly (D73.81)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
Does D70.2 need an additional code?
When the condition applies, yes. The Use Additional Code note reads: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5). The additional code is reported after D70.2.
Does D70.2 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage. D70.2 mapped to HCC 47 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 47 (Disorders of Immunity), ESRD (V21) category 47 (Disorders of Immunity), and ESRD (V24) category 47 (Disorders of Immunity).
